April 29, 2024 21:57 (IST)
Follow us:
Mumbai, Mar 14 (IBNS) Pharmaceutical major Pfizer has stopped manufacture and sale of popular cough syrup Corex with immediate effect after a ban by the Government.
“This is to inform you that the Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination of Chlopheniramine Maleate + Codeine Syrup with immediate effect,” Pfizer said in a BSE filing on Monday.
“In view of this, the company has discontinued the manufacture and sale of its drug Corex with immediate effect," it said.
Pfizer said it believed Corex had a "well-established efficacy and safety profile in India for more than 30 years," adding that the company was "exploring all possible options at its disposal."
Pfizer said the prohibition on Corex is likely to have an adverse impact on the revenue and profitability of the company.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Saudi Arabia pledges USD 500 million to protect children from polio Sun, Apr 28 2024
Truck gets caught in tornado on US highway; Video goes viral Sun, Apr 28 2024
6.1 magnitude earthquake hits Taiwan, no immediate damages reported Sat, Apr 27 2024
WHO says 'just in case’ antibiotics widely overused during COVID-19 Fri, Apr 26 2024
Conservation actions are effective at halting and reversing biodiversity loss, shows new study Fri, Apr 26 2024